Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5

• Κύριοι συγγραφείς: Zhaoyi Li (Συγγραφέας), Wenjing Cao (Συγγραφέας), Yuxuan Zhang (Συγγραφέας), Shanglei Lai (Συγγραφέας), Yingyan Ye (Συγγραφέας), Jianfeng Bao (Συγγραφέας), Ai Fu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introduction:Pueraria lobata is traditionally used in China for treatment of non-alcoholic fatty liver disease (NAFLD). Puerarin, a functional drug extracted from Pueraria lobata, features a pharmacological activity. The present study aims to investigate the effect of puerarin intervention on NAFLD....